IN2012DN02304A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02304A
IN2012DN02304A IN2304DEN2012A IN2012DN02304A IN 2012DN02304 A IN2012DN02304 A IN 2012DN02304A IN 2304DEN2012 A IN2304DEN2012 A IN 2304DEN2012A IN 2012DN02304 A IN2012DN02304 A IN 2012DN02304A
Authority
IN
India
Prior art keywords
aging
arnox
disorders
recombinant
nadh oxidase
Prior art date
Application number
Other languages
English (en)
Inventor
James D Morre
Xiaoyu Tang
Sara Dick
Christiaan Meadows
Dorothy M Morre
Original Assignee
Nox Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nox Technologies Inc filed Critical Nox Technologies Inc
Publication of IN2012DN02304A publication Critical patent/IN2012DN02304A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90209—Oxidoreductases (1.) acting on NADH or NADPH (1.6), e.g. those with a heme protein as acceptor (1.6.2) (general), Cytochrome-b5 reductase (1.6.2.2) or NADPH-cytochrome P450 reductase (1.6.2.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN2304DEN2012 2009-08-17 2010-08-17 IN2012DN02304A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23436809P 2009-08-17 2009-08-17
PCT/US2010/045745 WO2011022387A1 (en) 2009-08-17 2010-08-17 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility

Publications (1)

Publication Number Publication Date
IN2012DN02304A true IN2012DN02304A (ja) 2015-08-21

Family

ID=43607300

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2304DEN2012 IN2012DN02304A (ja) 2009-08-17 2010-08-17

Country Status (7)

Country Link
US (1) US20120315629A1 (ja)
EP (1) EP2467392A4 (ja)
JP (1) JP2013502217A (ja)
CN (1) CN102574889A (ja)
CA (1) CA2771277A1 (ja)
IN (1) IN2012DN02304A (ja)
WO (1) WO2011022387A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011109525A1 (en) 2010-03-02 2011-09-09 Nox Technologies, Inc. Aging-Related Circulating Particle-Associated Lipoprotein B Oxidase (apoBNOX) and Inhibitors Thereof
WO2014209280A1 (en) * 2013-06-25 2014-12-31 Mor-Nutech, Inc. Growth-related enox proteins from plants with yield enhancement potential, sequences and methods
CN114774418B (zh) * 2022-04-19 2023-11-14 深圳市人民医院 shRNA分子及其在敲低TM9SF2基因表达中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175787A1 (en) * 1997-10-28 2003-09-18 Incyte Corporation Vesicle membrane proteins
WO2005003766A2 (en) * 2003-06-13 2005-01-13 Whitehead Institute For Biomedical Research Methods of regulating metabolism and mitochondrial function
US7473531B1 (en) * 2003-08-08 2009-01-06 Colora Corporation Pancreatic cancer targets and uses thereof
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
SG182953A1 (en) * 2007-03-30 2012-08-30 Abbott Lab Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
AU2009207926B2 (en) * 2008-01-25 2014-06-19 Exosomics S.p.A. A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression

Also Published As

Publication number Publication date
WO2011022387A1 (en) 2011-02-24
CA2771277A1 (en) 2011-02-24
CN102574889A (zh) 2012-07-11
US20120315629A1 (en) 2012-12-13
WO2011022387A8 (en) 2012-03-29
JP2013502217A (ja) 2013-01-24
EP2467392A4 (en) 2013-06-19
EP2467392A1 (en) 2012-06-27

Similar Documents

Publication Publication Date Title
CL2007003649A1 (es) Un conjugado de molecula asociado a anticuerpo monoclonal humano anti-cd70; composicion que comprende al conjugado de molecula asociado a anticuerpo; metodo de inhibicion del crecimiento de celulas tumorales que expresan cd70.
AU2008298744A8 (en) MiRNA expression in human peripheral blood microvesicles and uses thereof
EP2293078A3 (en) Method for diagnosis of a bacterial infection
WO2008108803A3 (en) Immune cell biosensors and methods of using same
BRPI0811210A2 (pt) Agente de formação de imagem, composição farmacêutica, métodos de preparação de um agente de formação de imagem, de formação de imagem óptica in vivo do corpo de um mamífero e de detecção, avaliação do estágio, diagnóstico, monitoração da progressão da doença ou monitoração do tratamento de câncer colorretal do corpo de um mamífero, e, kit para a preparação da composição farmacêutica.
WO2008103645A8 (en) Prostate cancer and melanoma antigens
EP3885366A3 (en) Therapeutic antibodies against ror-1 protein and methods for use of same
EP1855719A4 (en) NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME
EP2068929A4 (en) METHOD OF DETECTING AND TREATING SKIN DISORDERS
UA105760C2 (uk) Антитіло проти bst2
NZ609567A (en) Markers of endothelial progenitor cells and uses thereof
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
US10718782B2 (en) Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
IN2012DN02304A (ja)
EA201690004A1 (ru) Антитела против lamp1 и конъюгаты антитела и лекарственного средства, а также их применение
BR112017022205A2 (pt) anticorpo anti-vegfr2 humano para terapia de câncer antiangiogênica e objetivada
WO2014117680A3 (zh) 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆
EP2539709A4 (en) ALTERNATIVES SPECIFIC TO ALZHEIMER'S DISEASE PROTEIN KINASE C EPSILON LEVELS (PKC-EPSILON)
MY148542A (en) A method for the assessment of cancer in a biological sample obtained from a subject
CN106947809A (zh) C6orf58基因在制备舌鳞癌诊治产品中的应用
HK1112630A1 (en) Antibodies against april as biomarkers for early prognosis of lymphoma patients
WO2009148363A3 (ru) Способ диагностики паразитарного заболевания
WO2010108245A3 (pt) Uso de antígenos de leishmania em método diagnóstico, vacina e terapia para leishmaniose
EA201001297A1 (ru) Способ диагностики меланомы человека на основании определения уровня экспрессии гена phf10, диагностический набор
WO2010093214A3 (en) Monoclonal antibody recognizing scye1 and use thereof